Pavlakis K, Alivizatos G, Mitropoulos D, Constantinides C, Skopelitou A, Kittas C, Dimopoulos C
Pathology Department of Athens Medical School, Greece.
Urol Int. 1992;49(3):137-40. doi: 10.1159/000282411.
Thirty-six transvesical or transurethral prostatectomy cases were selected from the histopathology files of the Laiko General Hospital. Among the 36 cases, there were 10 with benign prostatic hyperplasia (8 patients having distinct areas of adenosis) and 26 cases of prostatic adenocarcinoma (6 grade I, 13 grades II and III and 7 grade IV carcinomas). From each case, silver-binding nucleolar organizer regions (AgNORs) have been counted in sections of routinely processed paraffin-embedded tissue blocks. The mean AgNOR count per case was calculated. For the cases of prostatic hyperplasia, the mean AgNOR count was found to be 2.95 +/- 0.42, for adenosis 3.45 +/- 0.56, for grade I adenocarcinoma 4.97 +/- 0.74, for grades II and III 7.31 +/- 0.81 and for grade IV adenocarcinomas 11.41 +/- 1.68. This difference in the mean AgNOR count was found to be of statistical significance (p < 0.001) between adenosis and grade I adenocarcinomas and between grade II and III and grade IV adenocarcinomas. It appears that AgNOR counting may prove to be of benefit in differentiating between some benign and malignant prostatic lesions and that it might provide information concerning the biological behavior of prostatic adenocarcinomas.
从莱科综合医院的组织病理学档案中选取了36例经膀胱或经尿道前列腺切除术的病例。在这36例病例中,有10例为良性前列腺增生(8例有明显的腺病区域),26例为前列腺腺癌(6例为I级,13例为II级和III级,7例为IV级癌)。从每例病例中,在常规处理的石蜡包埋组织块切片中对银结合核仁组织区(AgNORs)进行计数。计算出每例病例的平均AgNOR计数。对于前列腺增生病例,发现平均AgNOR计数为2.95±0.42,腺病为3.45±0.56,I级腺癌为4.97±0.74,II级和III级为7.31±0.81,IV级腺癌为11.41±1.68。发现腺病与I级腺癌之间以及II级和III级与IV级腺癌之间的平均AgNOR计数差异具有统计学意义(p<0.001)。看来AgNOR计数可能有助于区分一些前列腺良性和恶性病变,并且可能提供有关前列腺腺癌生物学行为的信息。